ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

NCI Faces Major Cuts On Gramm-Rudman Sequestration; Grants, Centers, Trials Slashed

November 3, 1989

ACS’ Freeman; Declare New War In Cancer; Poor Get Substandard Treatment, Lost Dignity

July 21, 1989

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011